BCL2L11 Human (-)-demecolcine increases expression EXP 6480464 Demecolcine results in increased expression of BCL2L11 mRNA CTD PMID:23649840 BCL2L11 Human (S)-amphetamine multiple interactions EXP 6480464 [N-Methyl-3 more ... CTD PMID:23820845 BCL2L11 Human (S)-amphetamine increases expression EXP 6480464 Dextroamphetamine results in increased expression of BCL2L11 mRNA and Dextroamphetamine results in increased expression of BCL2L11 protein CTD PMID:23820845 BCL2L11 Human 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 o more ... CTD PMID:22937105 BCL2L11 Human 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane decreases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 o and p'-DDT analog results in decreased expression of BCL2L11 mRNA CTD PMID:22937105 BCL2L11 Human 1,1-dichloroethene increases expression ISO Bcl2l11 (Mus musculus) 6480464 vinylidene chloride results in increased expression of BCL2L11 mRNA CTD PMID:26682919 BCL2L11 Human 1,2-dimethylhydrazine decreases expression ISO Bcl2l11 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of BCL2L11 mRNA CTD PMID:22206623 BCL2L11 Human 1-[4,4-bis(4-fluorophenyl)butyl]-4-[4-chloro-3-(trifluoromethyl)phenyl]-4-piperidinol increases expression EXP 6480464 Penfluridol results in increased expression of BCL2L11 mRNA and Penfluridol results in increased expression of BCL2L11 protein CTD PMID:35530161 BCL2L11 Human 1-[4,4-bis(4-fluorophenyl)butyl]-4-[4-chloro-3-(trifluoromethyl)phenyl]-4-piperidinol multiple interactions EXP 6480464 dorsomorphin inhibits the reaction [Penfluridol results in increased expression of BCL2L11 mRNA] more ... CTD PMID:35530161 BCL2L11 Human 1-naphthyl isothiocyanate increases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 1-Naphthylisothiocyanate results in increased expression of BCL2L11 mRNA CTD PMID:30723492 BCL2L11 Human 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of BCL2L11 mRNA CTD PMID:21826169 BCL2L11 Human 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of BCL2L11 mRNA CTD PMID:23373633 more ... BCL2L11 Human 1H-pyrazole increases expression ISO Bcl2l11 (Mus musculus) 6480464 pyrazole results in increased expression of BCL2L11 mRNA CTD PMID:17945193 BCL2L11 Human 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 2 more ... CTD PMID:21851831 BCL2L11 Human 2,2',4,4'-Tetrabromodiphenyl ether affects expression EXP 6480464 2 more ... CTD PMID:27589474 BCL2L11 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of BCL2L11 mRNA CTD PMID:19520675 and PMID:33387578 BCL2L11 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Bcl2l11 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of BCL2L11 mRNA CTD PMID:34747641 BCL2L11 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Bcl2l11 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of BCL2L11 mRNA CTD PMID:15800033 more ... BCL2L11 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Bcl2l11 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of BCL2L11 mRNA CTD PMID:21570461 BCL2L11 Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 2 more ... CTD PMID:21851831 and PMID:25975270 BCL2L11 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Bcl2l11 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of BCL2L11 mRNA CTD PMID:19770486 BCL2L11 Human 2,4,6-trinitrobenzenesulfonic acid multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 [Trinitrobenzenesulfonic Acid results in increased expression of MAPK9 protein] promotes the reaction [BCL2L11 protein binds to MAPK9 protein] more ... CTD PMID:22427801 BCL2L11 Human 2,4,6-trinitrobenzenesulfonic acid increases expression ISO Bcl2l11 (Mus musculus) 6480464 Trinitrobenzenesulfonic Acid results in increased expression of BCL2L11 protein CTD PMID:22427801 BCL2L11 Human 2-butoxyethanol increases expression ISO Bcl2l11 (Mus musculus) 6480464 n-butoxyethanol results in increased expression of BCL2L11 mRNA CTD PMID:19812364 BCL2L11 Human 2-methoxyethanol increases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 methyl cellosolve results in increased expression of BCL2L11 mRNA CTD PMID:19643169 BCL2L11 Human 2-palmitoylglycerol increases expression EXP 6480464 2-palmitoylglycerol results in increased expression of BCL2L11 mRNA CTD PMID:37199045 BCL2L11 Human 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 3 more ... CTD PMID:23196670 BCL2L11 Human 3,4-methylenedioxymethamphetamine multiple interactions EXP 6480464 [N-Methyl-3 more ... CTD PMID:23820845 BCL2L11 Human 3,4-methylenedioxymethamphetamine increases expression EXP 6480464 N-Methyl-3 more ... CTD PMID:23820845 BCL2L11 Human 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BCL2L11 mRNA CTD PMID:28628672 BCL2L11 Human 4,4'-sulfonyldiphenol affects methylation ISO Bcl2l11 (Mus musculus) 6480464 bisphenol S affects the methylation of BCL2L11 gene CTD PMID:31683443 BCL2L11 Human 4-hydroxynon-2-enal increases expression ISO Bcl2l11 (Mus musculus) 6480464 4-hydroxy-2-nonenal results in increased expression of BCL2L11 mRNA CTD PMID:19191707 BCL2L11 Human 4-hydroxyphenyl retinamide increases expression ISO Bcl2l11 (Mus musculus) 6480464 Fenretinide results in increased expression of BCL2L11 mRNA CTD PMID:28973697 BCL2L11 Human 4-nitrophenol increases expression ISO Bcl2l11 (Mus musculus) 6480464 4-nitrophenol results in increased expression of BCL2L11 mRNA CTD PMID:34673133 BCL2L11 Human 4-nonylphenol increases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 4-nonylphenol results in increased expression of BCL2L11 protein CTD PMID:26804764 BCL2L11 Human 4-phenylbutyric acid multiple interactions ISO Bcl2l11 (Rattus norvegicus) 6480464 4-phenylbutyric acid inhibits the reaction [Methamphetamine results in increased expression of BCL2L11 protein] CTD PMID:34214594 BCL2L11 Human 4-vinylcyclohexene dioxide affects expression ISO Bcl2l11 (Mus musculus) 6480464 4-vinyl-1-cyclohexene dioxide affects the expression of BCL2L11 mRNA CTD PMID:20829426 BCL2L11 Human 5-aza-2'-deoxycytidine increases expression EXP 6480464 Decitabine results in increased expression of BCL2L11 mRNA and Decitabine results in increased expression of BCL2L11 protein CTD PMID:19403302 BCL2L11 Human 5-aza-2'-deoxycytidine decreases methylation EXP 6480464 Decitabine results in decreased methylation of BCL2L11 promoter CTD PMID:19403302 BCL2L11 Human 5-fluorouracil multiple interactions EXP 6480464 Fluorouracil affects the reaction [rebamipide results in decreased expression of BCL2L11 protein] and rebamipide inhibits the reaction [Fluorouracil results in increased expression of BCL2L11 protein] CTD PMID:29054700 BCL2L11 Human 5-fluorouracil increases expression EXP 6480464 Fluorouracil results in increased expression of BCL2L11 protein CTD PMID:29054700 BCL2L11 Human 7-ketocholesterol affects localization EXP 6480464 7-ketocholesterol affects the localization of BCL2L11 protein CTD PMID:15955068 BCL2L11 Human 8-(4-chlorophenylthio)-cAMP increases expression ISO Bcl2l11 (Mus musculus) 6480464 8-((4-chlorophenyl)thio)cyclic-3' more ... CTD PMID:14996839 BCL2L11 Human 8-(4-chlorophenylthio)-cAMP increases response to substance ISO Bcl2l11 (Mus musculus) 6480464 BCL2L11 protein results in increased susceptibility to 8-((4-chlorophenyl)thio)cyclic-3' and 5'-AMP CTD PMID:14996839 BCL2L11 Human 8-(4-chlorophenylthio)-cAMP increases response to substance EXP 6480464 BCL2L11 protein results in increased susceptibility to 8-((4-chlorophenyl)thio)cyclic-3' and 5'-AMP CTD PMID:14996839 BCL2L11 Human 8-(4-chlorophenylthio)-cAMP increases expression EXP 6480464 8-((4-chlorophenyl)thio)cyclic-3' and 5'-AMP results in increased expression of BCL2L11 protein CTD PMID:14996839 BCL2L11 Human 8-Br-cAMP multiple interactions EXP 6480464 [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of BCL2L11 protein CTD PMID:16709600 BCL2L11 Human 9,10-anthraquinone increases expression EXP 6480464 9 and 10-anthraquinone analog results in increased expression of BCL2L11 protein CTD PMID:26915975 BCL2L11 Human 9-cis-retinoic acid multiple interactions EXP 6480464 seocalcitol inhibits the reaction [Alitretinoin results in increased expression of BCL2L11 protein] CTD PMID:16340750 BCL2L11 Human 9-cis-retinoic acid increases expression EXP 6480464 Alitretinoin results in increased expression of BCL2L11 protein CTD PMID:16340750 BCL2L11 Human ABT-737 multiple interactions EXP 6480464 [ABT-737 inhibits the reaction [BCL2L11 protein binds to BCL2 protein]] promotes the reaction [BCL2L11 protein results in increased activity of BAX protein] more ... CTD PMID:17097560 more ... BCL2L11 Human ABT-737 increases response to substance ISO Bcl2l11 (Mus musculus) 6480464 BCL2L11 protein results in increased susceptibility to ABT-737 CTD PMID:20038611 BCL2L11 Human acetylsalicylic acid increases expression EXP 6480464 Aspirin results in increased expression of BCL2L11 mRNA CTD PMID:19936928 BCL2L11 Human acrolein multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of BCL2L11 mRNA more ... CTD PMID:32699268 and PMID:32845096 BCL2L11 Human actinomycin D multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 Dactinomycin inhibits the reaction [sodium arsenite results in increased expression of BCL2L11 mRNA] CTD PMID:16166651 BCL2L11 Human aflatoxin B1 increases expression ISO Bcl2l11 (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of BCL2L11 mRNA CTD PMID:19770486 BCL2L11 Human aflatoxin B1 increases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 Aflatoxin B1 results in increased expression of BCL2L11 mRNA CTD PMID:25378103 and PMID:33354967 BCL2L11 Human aldehydo-D-glucose increases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 Glucose results in increased expression of BCL2L11 protein CTD PMID:25471227 BCL2L11 Human aldehydo-D-glucose multiple interactions ISO Bcl2l11 (Rattus norvegicus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein]] and resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein] CTD PMID:25471227 BCL2L11 Human all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of BCL2L11 protein CTD PMID:19176369 BCL2L11 Human all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of BCL2L11 mRNA CTD PMID:33167477 BCL2L11 Human alpha-pinene multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of BCL2L11 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of BCL2L11 mRNA CTD PMID:32699268 BCL2L11 Human amiodarone increases expression EXP 6480464 Amiodarone results in increased expression of BCL2L11 mRNA CTD PMID:19774075 BCL2L11 Human ammonium chloride affects expression ISO Bcl2l11 (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of BCL2L11 mRNA CTD PMID:16483693 BCL2L11 Human ammonium chloride increases expression ISO Bcl2l11 (Mus musculus) 6480464 Ammonium Chloride results in increased expression of BCL2L11 mRNA CTD PMID:31310755 BCL2L11 Human anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [docetaxel results in increased degradation of BCL2L11 protein] more ... CTD PMID:17317842 more ... BCL2L11 Human anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 pyrazolanthrone inhibits the reaction [sodium arsenite results in increased expression of BCL2L11 protein] CTD PMID:16166651 BCL2L11 Human antirheumatic drug decreases expression EXP 6480464 Antirheumatic Agents results in decreased expression of BCL2L11 mRNA CTD PMID:24449571 BCL2L11 Human Aroclor 1254 increases expression ISO Bcl2l11 (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of BCL2L11 mRNA CTD PMID:25270620 BCL2L11 Human arsenous acid multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased degradation of BCL2L11 protein] more ... CTD PMID:21655183 more ... BCL2L11 Human arsenous acid increases degradation EXP 6480464 Arsenic Trioxide results in increased degradation of BCL2L11 protein CTD PMID:36509116 BCL2L11 Human arsenous acid affects expression EXP 6480464 Arsenic Trioxide affects the expression of BCL2L11 protein CTD PMID:36509116 BCL2L11 Human arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of BCL2L11 mRNA and Arsenic Trioxide results in increased expression of BCL2L11 protein CTD PMID:17203211 more ... BCL2L11 Human asbestos decreases expression EXP 6480464 Asbestos results in decreased expression of BCL2L11 CTD PMID:27042963 BCL2L11 Human Azaspiracid decreases expression EXP 6480464 azaspiracid results in decreased expression of BCL2L11 mRNA CTD PMID:28939011 BCL2L11 Human azoxystrobin decreases expression EXP 6480464 azoxystrobin results in decreased expression of BCL2L11 mRNA CTD PMID:33512557 BCL2L11 Human belinostat increases expression EXP 6480464 belinostat results in increased expression of BCL2L11 protein CTD PMID:18223231 BCL2L11 Human benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of BCL2L11 mRNA CTD PMID:15735009 BCL2L11 Human benzo[a]pyrene increases methylation EXP 6480464 Benzo(a)pyrene results in increased methylation of BCL2L11 3' UTR and Benzo(a)pyrene results in increased methylation of BCL2L11 5' UTR CTD PMID:27901495 BCL2L11 Human benzo[a]pyrene affects methylation EXP 6480464 Benzo(a)pyrene affects the methylation of BCL2L11 promoter CTD PMID:27901495 BCL2L11 Human benzo[a]pyrene decreases methylation ISO Bcl2l11 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased methylation of BCL2L11 3' UTR more ... CTD PMID:27901495 BCL2L11 Human benzo[a]pyrene increases methylation ISO Bcl2l11 (Mus musculus) 6480464 Benzo(a)pyrene results in increased methylation of BCL2L11 gene CTD PMID:28476633 BCL2L11 Human benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of BCL2L11 mRNA CTD PMID:26238291 BCL2L11 Human benzo[a]pyrene increases expression ISO Bcl2l11 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of BCL2L11 mRNA CTD PMID:19770486 and PMID:21715664 BCL2L11 Human benzo[a]pyrene decreases expression ISO Bcl2l11 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of BCL2L11 mRNA CTD PMID:20713471 BCL2L11 Human benzo[b]fluoranthene increases expression ISO Bcl2l11 (Mus musculus) 6480464 benzo(b)fluoranthene results in increased expression of BCL2L11 protein CTD PMID:21392559 BCL2L11 Human berberine multiple interactions EXP 6480464 [Berberine co-treated with Niacinamide] results in increased expression of BCL2L11 mRNA CTD PMID:26712469 BCL2L11 Human berberine increases expression EXP 6480464 Berberine results in increased expression of BCL2L11 mRNA CTD PMID:26712469 BCL2L11 Human bis(2-chloroethyl) sulfide increases expression ISO Bcl2l11 (Mus musculus) 6480464 Mustard Gas results in increased expression of BCL2L11 mRNA CTD PMID:18955075 BCL2L11 Human bis(2-ethylhexyl) phthalate increases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 Diethylhexyl Phthalate results in increased expression of BCL2L11 mRNA and Diethylhexyl Phthalate results in increased expression of BCL2L11 protein CTD PMID:22610992 and PMID:37979351 BCL2L11 Human bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of BCL2L11 mRNA CTD PMID:21826169 BCL2L11 Human bisphenol A increases methylation ISO Bcl2l11 (Rattus norvegicus) 6480464 bisphenol A results in increased methylation of BCL2L11 gene CTD PMID:28505145 BCL2L11 Human bisphenol A increases methylation ISO Bcl2l11 (Mus musculus) 6480464 bisphenol A results in increased methylation of BCL2L11 promoter CTD PMID:27312807 BCL2L11 Human bisphenol A multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BCL2L11 mRNA CTD PMID:28628672 BCL2L11 Human bisphenol A increases expression ISO Bcl2l11 (Mus musculus) 6480464 bisphenol A results in increased expression of BCL2L11 mRNA and bisphenol A results in increased expression of BCL2L11 protein CTD PMID:24909818 and PMID:32407858 BCL2L11 Human bisphenol A affects expression ISO Bcl2l11 (Rattus norvegicus) 6480464 bisphenol A affects the expression of BCL2L11 mRNA CTD PMID:25181051 BCL2L11 Human bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of BCL2L11 gene CTD PMID:22576693 BCL2L11 Human bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of BCL2L11 mRNA CTD PMID:22576693 BCL2L11 Human bortezomib multiple interactions EXP 6480464 [Bortezomib co-treated with romidepsin] results in increased expression of BCL2L11 protein more ... CTD PMID:15173094 and PMID:36509116 BCL2L11 Human bortezomib increases expression EXP 6480464 Bortezomib results in increased expression of BCL2L11 protein CTD PMID:16024631 more ... BCL2L11 Human bortezomib increases activity EXP 6480464 Bortezomib results in increased activity of BCL2L11 protein CTD PMID:16446371 BCL2L11 Human bortezomib increases response to substance EXP 6480464 BCL2L11 results in increased susceptibility to Bortezomib CTD PMID:18566236 BCL2L11 Human Brevetoxin B increases expression EXP 6480464 brevetoxin 2 results in increased expression of BCL2L11 mRNA CTD PMID:20498034 BCL2L11 Human bufalin increases expression EXP 6480464 bufalin results in increased expression of BCL2L11 protein CTD PMID:36924737 BCL2L11 Human cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of BCL2L11 CTD PMID:21787858 BCL2L11 Human cadmium dichloride increases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 Cadmium Chloride results in increased expression of BCL2L11 protein CTD PMID:28457857 BCL2L11 Human calcitriol decreases expression EXP 6480464 Calcitriol results in decreased expression of BCL2L11 mRNA CTD PMID:12071473 BCL2L11 Human cannabidiol affects expression ISO Bcl2l11 (Rattus norvegicus) 6480464 Cannabidiol affects the expression of BCL2L11 mRNA CTD PMID:38182033 BCL2L11 Human carbamazepine affects expression EXP 6480464 Carbamazepine affects the expression of BCL2L11 mRNA CTD PMID:24752500 BCL2L11 Human carbaryl decreases expression EXP 6480464 Carbaryl results in decreased expression of BCL2L11 mRNA CTD PMID:27829164 BCL2L11 Human carbon nanotube increases expression ISO Bcl2l11 (Mus musculus) 6480464 Nanotubes and Carbon analog results in increased expression of BCL2L11 mRNA CTD PMID:25554681 BCL2L11 Human chlorpyrifos increases expression ISO Bcl2l11 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of BCL2L11 mRNA CTD PMID:27737797 BCL2L11 Human chlorpyrifos multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 Chlorpyrifos promotes the reaction [Streptozocin results in increased expression of BCL2L11 mRNA] CTD PMID:33524429 BCL2L11 Human chromium(6+) increases expression EXP 6480464 chromium hexavalent ion results in increased expression of BCL2L11 mRNA CTD PMID:17382205 BCL2L11 Human chromium(6+) multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 [sodium chromate(VI) results in increased abundance of chromium hexavalent ion] which results in increased expression of BCL2L11 mRNA and Melatonin inhibits the reaction [[sodium chromate(VI) results in increased abundance of chromium hexavalent ion] which results in increased expression of BCL2L11 mRNA] CTD PMID:35643323 BCL2L11 Human chromium(6+) affects expression ISO Bcl2l11 (Mus musculus) 6480464 chromium hexavalent ion affects the expression of BCL2L11 mRNA CTD PMID:28472532 BCL2L11 Human cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of BCL2L11 mRNA more ... CTD PMID:21092744 and PMID:27392435 BCL2L11 Human cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of BCL2L11 mRNA CTD PMID:21092744 more ... BCL2L11 Human clofibrate multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of BCL2L11 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of BCL2L11 mRNA] CTD PMID:17585979 BCL2L11 Human cobalt dichloride increases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 cobaltous chloride results in increased expression of BCL2L11 mRNA CTD PMID:24386269 BCL2L11 Human cobalt dichloride multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 [cobaltous chloride co-treated with lipopolysaccharide more ... CTD PMID:32408695 BCL2L11 Human cobimetinib increases expression EXP 6480464 cobimetinib results in increased expression of BCL2L11 protein and cobimetinib results in increased expression of BCL2L11 protein alternative form CTD PMID:22084396 BCL2L11 Human cobimetinib multiple interactions EXP 6480464 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3 more ... CTD PMID:22084396 BCL2L11 Human cocaine increases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 Cocaine results in increased expression of BCL2L11 mRNA CTD PMID:16076954 BCL2L11 Human copper atom multiple interactions ISO Bcl2l11 (Rattus norvegicus) 6480464 [Copper deficiency co-treated with tetrathiomolybdate] results in increased cleavage of BCL2L11 protein and [Copper deficiency co-treated with tetrathiomolybdate] results in increased expression of BCL2L11 protein CTD PMID:22276220 BCL2L11 Human copper(0) multiple interactions ISO Bcl2l11 (Rattus norvegicus) 6480464 [Copper deficiency co-treated with tetrathiomolybdate] results in increased cleavage of BCL2L11 protein and [Copper deficiency co-treated with tetrathiomolybdate] results in increased expression of BCL2L11 protein CTD PMID:22276220 BCL2L11 Human crizotinib increases expression EXP 6480464 crizotinib results in increased expression of BCL2L11 protein CTD PMID:22729845 BCL2L11 Human crizotinib multiple interactions EXP 6480464 BCL2L11 protein affects the reaction [crizotinib results in increased cleavage of CASP3 protein] and MET gene mutant form promotes the reaction [crizotinib results in increased expression of BCL2L11 protein] CTD PMID:22729845 BCL2L11 Human crizotinib affects response to substance EXP 6480464 BCL2L11 protein affects the susceptibility to crizotinib CTD PMID:22729845 BCL2L11 Human crocidolite asbestos decreases expression EXP 6480464 Asbestos and Crocidolite results in decreased expression of BCL2L11 mRNA CTD PMID:18687144 BCL2L11 Human cucurbitacin B increases expression EXP 6480464 cucurbitacin B results in increased expression of BCL2L11 mRNA CTD PMID:26183715 BCL2L11 Human cucurbitacin B multiple interactions EXP 6480464 [cucurbitacin B co-treated with Gefitinib] results in increased expression of BCL2L11 mRNA CTD PMID:26183715 BCL2L11 Human Cuprizon increases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 Cuprizone results in increased expression of BCL2L11 mRNA CTD PMID:25704630 BCL2L11 Human curcumin increases expression EXP 6480464 Curcumin results in increased expression of BCL2L11 mRNA CTD PMID:17332930 BCL2L11 Human curcumin multiple interactions EXP 6480464 [arsenic trioxide co-treated with Curcumin] results in increased expression of BCL2L11 protein CTD PMID:27430728 BCL2L11 Human cyclophosphamide increases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 Cyclophosphamide results in increased expression of BCL2L11 mRNA CTD PMID:32197949 BCL2L11 Human cyclophosphamide multiple interactions ISO Bcl2l11 (Rattus norvegicus) 6480464 sacubitril and valsartan sodium hydrate drug combination inhibits the reaction [Cyclophosphamide results in increased expression of BCL2L11 mRNA] and Valsartan inhibits the reaction [Cyclophosphamide results in increased expression of BCL2L11 mRNA] CTD PMID:32197949 BCL2L11 Human D-glucose multiple interactions ISO Bcl2l11 (Rattus norvegicus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein]] and resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein] CTD PMID:25471227 BCL2L11 Human D-glucose increases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 Glucose results in increased expression of BCL2L11 protein CTD PMID:25471227 BCL2L11 Human dactolisib affects expression EXP 6480464 dactolisib affects the expression of BCL2L11 protein CTD PMID:25640480 BCL2L11 Human dantrolene multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 Dantrolene inhibits the reaction [Halothane results in increased expression of BCL2L11 mRNA] CTD PMID:32795494 BCL2L11 Human DDE affects expression ISO Bcl2l11 (Rattus norvegicus) 6480464 Dichlorodiphenyl Dichloroethylene affects the expression of BCL2L11 mRNA CTD PMID:24576310 BCL2L11 Human deguelin decreases expression EXP 6480464 deguelin results in decreased expression of BCL2L11 mRNA CTD PMID:33512557 BCL2L11 Human dexamethasone increases response to substance EXP 6480464 BCL2L11 protein results in increased susceptibility to Dexamethasone CTD PMID:14996839 BCL2L11 Human dexamethasone increases response to substance ISO Bcl2l11 (Mus musculus) 6480464 BCL2L11 protein results in increased susceptibility to Dexamethasone CTD PMID:14996839 BCL2L11 Human dexamethasone increases expression ISO Bcl2l11 (Mus musculus) 6480464 Dexamethasone results in increased expression of BCL2L11 mRNA alternative form and Dexamethasone results in increased expression of BCL2L11 protein CTD PMID:14996839 and PMID:17953376 BCL2L11 Human dexamethasone multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BCL2L11 mRNA more ... CTD PMID:18515658 more ... BCL2L11 Human dexamethasone increases phosphorylation EXP 6480464 Dexamethasone results in increased phosphorylation of BCL2L11 protein CTD PMID:20067466 BCL2L11 Human dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of BCL2L11 mRNA CTD PMID:12782123 BCL2L11 Human Di-n-octyl phthalate decreases expression ISO Bcl2l11 (Mus musculus) 6480464 di-n-octyl phthalate results in decreased expression of BCL2L11 protein CTD PMID:29128616 BCL2L11 Human diarsenic trioxide multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased degradation of BCL2L11 protein] more ... CTD PMID:21655183 more ... BCL2L11 Human diarsenic trioxide increases degradation EXP 6480464 Arsenic Trioxide results in increased degradation of BCL2L11 protein CTD PMID:36509116 BCL2L11 Human diarsenic trioxide affects expression EXP 6480464 Arsenic Trioxide affects the expression of BCL2L11 protein CTD PMID:36509116 BCL2L11 Human diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of BCL2L11 mRNA and Arsenic Trioxide results in increased expression of BCL2L11 protein CTD PMID:17203211 more ... BCL2L11 Human dibenzo[a,l]pyrene increases methylation ISO Bcl2l11 (Mus musculus) 6480464 dibenzo(a and l)pyrene results in increased methylation of BCL2L11 gene CTD PMID:28476633 BCL2L11 Human dibutyl phthalate decreases expression ISO Bcl2l11 (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of BCL2L11 mRNA CTD PMID:17361019 and PMID:21266533 BCL2L11 Human diclofenac affects expression EXP 6480464 Diclofenac affects the expression of BCL2L11 mRNA CTD PMID:24752500 BCL2L11 Human dicrotophos increases expression EXP 6480464 dicrotophos results in increased expression of BCL2L11 mRNA CTD PMID:28302478 BCL2L11 Human dieldrin affects expression ISO Bcl2l11 (Rattus norvegicus) 6480464 Dieldrin affects the expression of BCL2L11 mRNA CTD PMID:22546817 BCL2L11 Human diepoxybutane increases expression EXP 6480464 diepoxybutane results in increased expression of BCL2L11 mRNA CTD PMID:29792945 BCL2L11 Human diethyl malate increases expression EXP 6480464 diethyl malate results in increased expression of BCL2L11 mRNA CTD PMID:38498338 BCL2L11 Human dinophysistoxin 1 increases expression EXP 6480464 dinophysistoxin 1 results in increased expression of BCL2L11 mRNA CTD PMID:28939011 BCL2L11 Human dioxygen multiple interactions EXP 6480464 [Oxygen co-treated with Oxygen deficiency] results in increased expression of BCL2L11 protein more ... CTD PMID:25472572 BCL2L11 Human dioxygen multiple interactions ISO Bcl2l11 (Rattus norvegicus) 6480464 [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of BCL2L11 mRNA] and [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of BCL2L11 mRNA CTD PMID:33729688 BCL2L11 Human diquat increases expression ISO Bcl2l11 (Mus musculus) 6480464 Diquat results in increased expression of BCL2L11 mRNA CTD PMID:26785375 and PMID:27057282 BCL2L11 Human diquat multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 procyanidin B2 inhibits the reaction [Diquat results in increased expression of BCL2L11 mRNA] CTD PMID:27057282 BCL2L11 Human disulfiram increases expression EXP 6480464 Disulfiram results in increased expression of BCL2L11 mRNA CTD PMID:34182011 BCL2L11 Human dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 and PMID:35530161 BCL2L11 Human doxorubicin multiple interactions EXP 6480464 [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with Doxorubicin] results in decreased phosphorylation of BCL2L11 protein more ... CTD PMID:17339365 and PMID:20856197 BCL2L11 Human doxorubicin multiple interactions ISO Bcl2l11 (Rattus norvegicus) 6480464 5-amino-7-(cyclohexylamino)-1-ethyl-6-fluoro-4-oxo-1 more ... CTD PMID:32075913 BCL2L11 Human doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of BCL2L11 protein CTD PMID:25339540 BCL2L11 Human doxorubicin increases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 Doxorubicin results in increased expression of BCL2L11 mRNA and Doxorubicin results in increased expression of BCL2L11 protein CTD PMID:26318906 and PMID:32075913 BCL2L11 Human doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of BCL2L11 protein CTD PMID:17339365 BCL2L11 Human efavirenz increases response to substance EXP 6480464 BCL2L11 protein results in increased susceptibility to efavirenz metabolite CTD PMID:21958719 BCL2L11 Human efavirenz increases expression EXP 6480464 efavirenz metabolite results in increased expression of BCL2L11 mRNA more ... CTD PMID:21958719 BCL2L11 Human elemental selenium multiple interactions EXP 6480464 BCL2L11 protein affects the susceptibility to [Doxorubicin co-treated with Selenium] more ... CTD PMID:17339365 BCL2L11 Human elemental selenium increases expression EXP 6480464 Selenium results in increased expression of BCL2L11 protein CTD PMID:17339365 BCL2L11 Human endosulfan increases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 Endosulfan results in increased expression of BCL2L11 mRNA CTD PMID:29391264 BCL2L11 Human enniatin decreases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 enniatins results in decreased expression of BCL2L11 mRNA CTD PMID:27163883 BCL2L11 Human entinostat decreases expression EXP 6480464 entinostat results in decreased expression of BCL2L11 mRNA CTD PMID:26272509 BCL2L11 Human entinostat multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BCL2L11 mRNA CTD PMID:27188386 BCL2L11 Human epichlorohydrin decreases expression EXP 6480464 Epichlorohydrin results in decreased expression of BCL2L11 mRNA CTD PMID:29792945 BCL2L11 Human epoxiconazole increases expression ISO Bcl2l11 (Mus musculus) 6480464 epoxiconazole results in increased expression of BCL2L11 mRNA CTD PMID:35436446 BCL2L11 Human erlotinib hydrochloride increases expression EXP 6480464 Erlotinib Hydrochloride results in increased expression of BCL2L11 protein CTD PMID:30171258 BCL2L11 Human erlotinib hydrochloride multiple interactions EXP 6480464 Harmine promotes the reaction [Erlotinib Hydrochloride results in increased expression of BCL2L11 protein] CTD PMID:30171258 BCL2L11 Human ethanol increases expression ISO Bcl2l11 (Mus musculus) 6480464 Ethanol results in increased expression of BCL2L11 mRNA CTD PMID:24095927 BCL2L11 Human ethanol multiple interactions EXP 6480464 [Ethanol co-treated with FOXO3 protein] results in increased expression of BCL2L11 mRNA more ... CTD PMID:26470730 BCL2L11 Human ethyl methanesulfonate increases expression EXP 6480464 Ethyl Methanesulfonate results in increased expression of BCL2L11 mRNA CTD PMID:23649840 BCL2L11 Human ferric oxide increases expression ISO Bcl2l11 (Mus musculus) 6480464 ferric oxide analog results in increased expression of BCL2L11 mRNA and ferric oxide analog results in increased expression of BCL2L11 protein CTD PMID:24525745 and PMID:25086211 BCL2L11 Human flutamide multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 CBL protein affects the reaction [Flutamide results in increased expression of BCL2L11 protein] CTD PMID:16301331 BCL2L11 Human flutamide increases expression ISO Bcl2l11 (Mus musculus) 6480464 Flutamide results in increased expression of BCL2L11 protein CTD PMID:16301331 BCL2L11 Human flutamide increases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 Flutamide results in increased expression of BCL2L11 mRNA and Flutamide results in increased expression of BCL2L11 protein CTD PMID:20850791 and PMID:24793618 BCL2L11 Human fluvastatin multiple interactions EXP 6480464 [zoledronic acid co-treated with fluvastatin] results in increased expression of BCL2L11 mRNA CTD PMID:16996129 BCL2L11 Human folic acid affects expression EXP 6480464 Folic Acid affects the expression of BCL2L11 mRNA CTD PMID:16361273 BCL2L11 Human formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of BCL2L11 mRNA CTD PMID:23649840 BCL2L11 Human furan increases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 furan results in increased expression of BCL2L11 mRNA CTD PMID:20562052 more ... BCL2L11 Human furosemide affects expression ISO Bcl2l11 (Rattus norvegicus) 6480464 Furosemide affects the expression of BCL2L11 mRNA CTD PMID:17497460 BCL2L11 Human gallic acid decreases expression ISO Bcl2l11 (Mus musculus) 6480464 Gallic Acid results in decreased expression of BCL2L11 mRNA CTD PMID:29205955 BCL2L11 Human gefitinib increases response to substance EXP 6480464 BCL2L11 protein results in increased susceptibility to gefitinib CTD PMID:20237869 BCL2L11 Human gefitinib multiple interactions EXP 6480464 [cucurbitacin B co-treated with Gefitinib] results in increased expression of BCL2L11 mRNA CTD PMID:26183715 BCL2L11 Human gemcitabine increases expression EXP 6480464 Gemcitabine results in increased expression of BCL2L11 mRNA CTD PMID:17039268 BCL2L11 Human gentamycin decreases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 Gentamicins results in decreased expression of BCL2L11 mRNA CTD PMID:33387578 BCL2L11 Human Gingerenone A increases expression EXP 6480464 gingerenone A results in increased expression of BCL2L11 protein modified form CTD PMID:26242912 BCL2L11 Human glucose multiple interactions ISO Bcl2l11 (Rattus norvegicus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein]] and resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein] CTD PMID:25471227 BCL2L11 Human glucose increases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 Glucose results in increased expression of BCL2L11 protein CTD PMID:25471227 BCL2L11 Human gold atom decreases expression EXP 6480464 Gold analog results in decreased expression of BCL2L11 mRNA CTD PMID:36057382 BCL2L11 Human gold(0) decreases expression EXP 6480464 Gold analog results in decreased expression of BCL2L11 mRNA CTD PMID:36057382 BCL2L11 Human gossypol increases expression EXP 6480464 Gossypol results in increased expression of BCL2L11 protein CTD PMID:18840529 BCL2L11 Human GW 6471 multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 GW 6471 inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of BCL2L11 protein] CTD PMID:37979351 BCL2L11 Human halothane multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 [Ryanodine co-treated with Halothane] results in increased expression of BCL2L11 mRNA and Dantrolene inhibits the reaction [Halothane results in increased expression of BCL2L11 mRNA] CTD PMID:32795494 BCL2L11 Human halothane increases expression ISO Bcl2l11 (Mus musculus) 6480464 Halothane results in increased expression of BCL2L11 mRNA CTD PMID:32795494 BCL2L11 Human harmine multiple interactions EXP 6480464 Harmine promotes the reaction [Erlotinib Hydrochloride results in increased expression of BCL2L11 protein] CTD PMID:30171258 BCL2L11 Human hydrogen peroxide multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 procyanidin B2 inhibits the reaction [Hydrogen Peroxide results in increased expression of BCL2L11 mRNA] CTD PMID:27057282 BCL2L11 Human hydrogen peroxide increases expression ISO Bcl2l11 (Mus musculus) 6480464 Hydrogen Peroxide results in increased expression of BCL2L11 mRNA CTD PMID:27057282 BCL2L11 Human ibrutinib multiple interactions EXP 6480464 ibrutinib promotes the reaction [(+)-JQ1 compound results in increased expression of BCL2L11 protein] CTD PMID:26254443 BCL2L11 Human icariin affects expression ISO Bcl2l11 (Rattus norvegicus) 6480464 icariin affects the expression of BCL2L11 protein CTD PMID:25472572 BCL2L11 Human icariin multiple interactions EXP 6480464 icariin inhibits the reaction [[Oxygen co-treated with Oxygen deficiency] results in increased expression of BCL2L11 protein] CTD PMID:25472572 BCL2L11 Human indole-3-methanol increases expression EXP 6480464 indole-3-carbinol results in increased expression of BCL2L11 protein CTD PMID:33118390 and PMID:34085558 BCL2L11 Human indometacin multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BCL2L11 mRNA CTD PMID:28628672 BCL2L11 Human isoflurane decreases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 Isoflurane results in decreased expression of BCL2L11 mRNA CTD PMID:16978161 BCL2L11 Human isoprenaline increases expression ISO Bcl2l11 (Mus musculus) 6480464 Isoproterenol results in increased expression of BCL2L11 protein CTD PMID:14996839 BCL2L11 Human isoprenaline increases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 Isoproterenol results in increased expression of BCL2L11 mRNA CTD PMID:24286936 BCL2L11 Human isoprenaline increases expression EXP 6480464 Isoproterenol results in increased expression of BCL2L11 mRNA CTD PMID:24286936 BCL2L11 Human ketoconazole increases expression ISO Bcl2l11 (Mus musculus) 6480464 Ketoconazole results in increased expression of BCL2L11 mRNA CTD PMID:25808816 BCL2L11 Human lead diacetate increases expression ISO Bcl2l11 (Mus musculus) 6480464 lead acetate results in increased expression of BCL2L11 mRNA CTD PMID:21829687 BCL2L11 Human lovastatin multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [Lovastatin results in increased expression of BCL2L11 protein] CTD PMID:18766339 BCL2L11 Human lovastatin multiple interactions ISO Bcl2l11 (Rattus norvegicus) 6480464 Lovastatin inhibits the reaction [Cholesterol and Dietary results in increased expression of BCL2L11 protein] CTD PMID:35734936 BCL2L11 Human lovastatin increases expression EXP 6480464 Lovastatin results in increased expression of BCL2L11 protein CTD PMID:18766339 BCL2L11 Human LY294002 multiple interactions ISO Bcl2l11 (Rattus norvegicus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein]] CTD PMID:25471227 BCL2L11 Human LY294002 increases expression EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of BCL2L11 protein alternative form CTD PMID:21179458 BCL2L11 Human LY294002 multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rebamipide results in decreased expression of BCL2L11 protein] more ... CTD PMID:20856197 more ... BCL2L11 Human maneb multiple interactions EXP 6480464 [Paraquat co-treated with Maneb] results in increased expression of BCL2L11 protein CTD PMID:18266926 BCL2L11 Human maneb increases expression EXP 6480464 Maneb results in increased expression of BCL2L11 protein CTD PMID:18266926 BCL2L11 Human manganese(II) chloride increases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 manganese chloride results in increased expression of BCL2L11 protein CTD PMID:25732873 BCL2L11 Human manganese(II) chloride decreases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 manganese chloride results in decreased expression of BCL2L11 mRNA CTD PMID:28801915 BCL2L11 Human medroxyprogesterone acetate multiple interactions EXP 6480464 [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of BCL2L11 protein CTD PMID:16709600 BCL2L11 Human melatonin multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 Melatonin inhibits the reaction [[sodium chromate(VI) results in increased abundance of chromium hexavalent ion] which results in increased expression of BCL2L11 mRNA] CTD PMID:35643323 BCL2L11 Human mercury atom decreases expression EXP 6480464 Mercury results in decreased expression of BCL2L11 mRNA CTD PMID:19937285 BCL2L11 Human mercury dibromide decreases expression EXP 6480464 mercuric bromide results in decreased expression of BCL2L11 mRNA CTD PMID:26272509 BCL2L11 Human mercury dibromide multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BCL2L11 mRNA CTD PMID:27188386 BCL2L11 Human mercury(0) decreases expression EXP 6480464 Mercury results in decreased expression of BCL2L11 mRNA CTD PMID:19937285 BCL2L11 Human methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of BCL2L11 protein CTD PMID:23820845 BCL2L11 Human methamphetamine increases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 Methamphetamine results in increased expression of BCL2L11 protein CTD PMID:34214594 BCL2L11 Human methamphetamine multiple interactions ISO Bcl2l11 (Rattus norvegicus) 6480464 4-phenylbutyric acid inhibits the reaction [Methamphetamine results in increased expression of BCL2L11 protein] and DDIT3 protein affects the reaction [Methamphetamine results in increased expression of BCL2L11 protein] CTD PMID:34214594 BCL2L11 Human methamphetamine multiple interactions EXP 6480464 [N-Methyl-3 more ... CTD PMID:23820845 BCL2L11 Human methoxychlor affects methylation ISO Bcl2l11 (Rattus norvegicus) 6480464 Methoxychlor affects the methylation of BCL2L11 gene CTD PMID:35440735 BCL2L11 Human methyl methanesulfonate increases expression EXP 6480464 Methyl Methanesulfonate results in increased expression of BCL2L11 mRNA CTD PMID:23649840 BCL2L11 Human methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of BCL2L11 mRNA CTD PMID:28001369 BCL2L11 Human methylparaben increases expression EXP 6480464 methylparaben results in increased expression of BCL2L11 mRNA CTD PMID:24481588 BCL2L11 Human methylseleninic acid multiple interactions EXP 6480464 BCL2L11 protein affects the susceptibility to [Doxorubicin co-treated with methylselenic acid] more ... CTD PMID:17339365 and PMID:18790785 BCL2L11 Human methylseleninic acid increases expression EXP 6480464 methylselenic acid results in increased expression of BCL2L11 mRNA and methylselenic acid results in increased expression of BCL2L11 protein CTD PMID:17339365 and PMID:28161410 BCL2L11 Human methylseleninic acid increases cleavage EXP 6480464 methylselenic acid results in increased cleavage of BCL2L11 protein CTD PMID:18790785 BCL2L11 Human microcystin-LR increases expression ISO Bcl2l11 (Mus musculus) 6480464 cyanoginosin LR results in increased expression of BCL2L11 mRNA CTD PMID:17654400 BCL2L11 Human Mitotane increases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 Mitotane results in increased expression of BCL2L11 mRNA CTD PMID:23485034 BCL2L11 Human MK-2206 multiple interactions EXP 6480464 [mirdametinib co-treated with MK 2206] results in increased expression of BCL2L11 protein more ... CTD PMID:27634878 BCL2L11 Human mono(2-ethylhexyl) phthalate multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 GW 6471 inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of BCL2L11 protein] CTD PMID:37979351 BCL2L11 Human mono(2-ethylhexyl) phthalate increases expression ISO Bcl2l11 (Mus musculus) 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of BCL2L11 protein CTD PMID:37979351 BCL2L11 Human monodansylcadaverine increases expression EXP 6480464 monodansylcadaverine results in increased expression of BCL2L11 protein CTD PMID:16170020 BCL2L11 Human monosodium L-glutamate multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 [Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of BCL2L11 mRNA CTD PMID:19001666 BCL2L11 Human monosodium L-glutamate increases expression ISO Bcl2l11 (Mus musculus) 6480464 Sodium Glutamate results in increased expression of BCL2L11 mRNA CTD PMID:19001666 BCL2L11 Human morphine increases expression EXP 6480464 Morphine results in increased expression of BCL2L11 protein CTD PMID:19292871 BCL2L11 Human N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [[Bortezomib co-treated with romidepsin] results in increased expression of BCL2L11 protein] CTD PMID:15173094 BCL2L11 Human N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Arsenic Trioxide results in increased degradation of BCL2L11 protein] CTD PMID:36509116 BCL2L11 Human N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of BCL2L11 mRNA CTD PMID:18266926 BCL2L11 Human N-methyl-4-phenylpyridinium decreases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of BCL2L11 mRNA CTD PMID:28801915 BCL2L11 Human N-methyl-4-phenylpyridinium increases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of BCL2L11 mRNA and 1-Methyl-4-phenylpyridinium results in increased expression of BCL2L11 protein CTD PMID:28770951 BCL2L11 Human N-methyl-4-phenylpyridinium multiple interactions ISO Bcl2l11 (Rattus norvegicus) 6480464 MIR181C mRNA inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BCL2L11 mRNA] and MIR181C mRNA inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BCL2L11 protein] CTD PMID:28770951 BCL2L11 Human N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions ISO Bcl2l11 (Rattus norvegicus) 6480464 [Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of BCL2L11 protein and S-allylcysteine inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of BCL2L11 protein] CTD PMID:16030430 BCL2L11 Human N-nitrosodiethylamine increases expression ISO Bcl2l11 (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of BCL2L11 mRNA CTD PMID:24535843 BCL2L11 Human nickel atom multiple interactions EXP 6480464 trichostatin A inhibits the reaction [Nickel affects the expression of BCL2L11 mRNA] CTD PMID:14575637 BCL2L11 Human nickel atom affects expression EXP 6480464 Nickel affects the expression of BCL2L11 mRNA CTD PMID:14575637 BCL2L11 Human nickel dichloride affects expression ISO Bcl2l11 (Rattus norvegicus) 6480464 nickel chloride affects the expression of BCL2L11 mRNA CTD PMID:22110744 BCL2L11 Human nickel sulfate increases expression EXP 6480464 nickel sulfate results in increased expression of BCL2L11 mRNA CTD PMID:17382205 BCL2L11 Human nicotinamide multiple interactions EXP 6480464 [Berberine co-treated with Niacinamide] results in increased expression of BCL2L11 mRNA and Niacinamide promotes the reaction [[Oxygen co-treated with Oxygen deficiency] results in increased expression of BCL2L11 protein] CTD PMID:25472572 and PMID:26712469 BCL2L11 Human nicotinamide increases expression EXP 6480464 Niacinamide results in increased expression of BCL2L11 mRNA CTD PMID:26712469 BCL2L11 Human nimustine increases expression EXP 6480464 Nimustine results in increased expression of BCL2L11 mRNA and Nimustine results in increased expression of BCL2L11 protein CTD PMID:26418950 BCL2L11 Human nimustine multiple interactions EXP 6480464 BCL2L11 mutant form inhibits the reaction [Nimustine results in increased cleavage of CASP9 protein] and pyrazolanthrone inhibits the reaction [Nimustine results in increased expression of BCL2L11 mRNA] CTD PMID:26418950 BCL2L11 Human NORCANTHARIDIN increases expression EXP 6480464 norcantharidin results in increased expression of BCL2L11 protein alternative form CTD PMID:29193574 BCL2L11 Human ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of BCL2L11 mRNA CTD PMID:30559759 and PMID:30763683 BCL2L11 Human okadaic acid increases expression EXP 6480464 Okadaic Acid results in increased expression of BCL2L11 mRNA CTD PMID:28939011 BCL2L11 Human omipalisib multiple interactions EXP 6480464 [trametinib co-treated with omipalisib] results in increased expression of BCL2L11 protein CTD PMID:22733540 BCL2L11 Human osthole increases expression EXP 6480464 osthol results in increased expression of BCL2L11 protein alternative form CTD PMID:29319219 BCL2L11 Human ozone multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of BCL2L11 mRNA more ... CTD PMID:32699268 and PMID:32845096 BCL2L11 Human ozone multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of BCL2L11 mRNA CTD PMID:34911549 BCL2L11 Human p-chloromercuribenzoic acid decreases expression EXP 6480464 p-Chloromercuribenzoic Acid results in decreased expression of BCL2L11 mRNA CTD PMID:26272509 BCL2L11 Human p-chloromercuribenzoic acid multiple interactions EXP 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BCL2L11 mRNA CTD PMID:27188386 BCL2L11 Human paclitaxel affects response to substance ISO Bcl2l11 (Mus musculus) 6480464 BCL2L11 protein affects the susceptibility to Paclitaxel CTD PMID:17652622 BCL2L11 Human panobinostat decreases expression EXP 6480464 panobinostat results in decreased expression of BCL2L11 mRNA CTD PMID:26272509 BCL2L11 Human panobinostat multiple interactions EXP 6480464 (+)-JQ1 compound promotes the reaction [Panobinostat results in increased expression of BCL2L11 protein] more ... CTD PMID:24435446 and PMID:27188386 BCL2L11 Human panobinostat increases expression EXP 6480464 panobinostat results in increased expression of BCL2L11 protein CTD PMID:24435446 BCL2L11 Human paracetamol multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of BCL2L11 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of BCL2L11 mRNA] CTD PMID:17585979 BCL2L11 Human paracetamol increases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 Acetaminophen results in increased expression of BCL2L11 mRNA CTD PMID:33387578 BCL2L11 Human paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of BCL2L11 mRNA CTD PMID:26690555 BCL2L11 Human paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of BCL2L11 mRNA CTD PMID:21420995 and PMID:25704631 BCL2L11 Human paracetamol affects expression ISO Bcl2l11 (Mus musculus) 6480464 Acetaminophen affects the expression of BCL2L11 mRNA CTD PMID:17562736 BCL2L11 Human paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of BCL2L11 mRNA CTD PMID:18836921 BCL2L11 Human paraquat multiple interactions EXP 6480464 [Paraquat co-treated with Maneb] results in increased expression of BCL2L11 protein CTD PMID:18266926 BCL2L11 Human paraquat increases expression EXP 6480464 Paraquat results in increased expression of BCL2L11 protein CTD PMID:18266926 BCL2L11 Human paraquat multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 FOXO3 mutant form inhibits the reaction [Paraquat results in increased expression of BCL2L11 mRNA] CTD PMID:23620592 BCL2L11 Human paraquat increases expression ISO Bcl2l11 (Mus musculus) 6480464 Paraquat results in increased expression of BCL2L11 mRNA CTD PMID:23620592 BCL2L11 Human patulin increases expression EXP 6480464 Patulin results in increased expression of BCL2L11 mRNA CTD PMID:21844328 BCL2L11 Human PD 0325901 multiple interactions EXP 6480464 [mirdametinib co-treated with MK 2206] results in increased expression of BCL2L11 protein more ... CTD PMID:24576621 and PMID:27634878 BCL2L11 Human PD 0325901 increases expression EXP 6480464 mirdametinib results in increased expression of BCL2L11 protein CTD PMID:24576621 and PMID:27634878 BCL2L11 Human perfluorooctane-1-sulfonic acid multiple interactions ISO Bcl2l11 (Rattus norvegicus) 6480464 FOXO3 protein affects the reaction [perfluorooctane sulfonic acid results in increased expression of BCL2L11 protein] CTD PMID:31588057 BCL2L11 Human perfluorooctane-1-sulfonic acid increases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 perfluorooctane sulfonic acid results in increased expression of BCL2L11 protein CTD PMID:31588057 BCL2L11 Human perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of BCL2L11 protein CTD PMID:35123991 BCL2L11 Human pevonedistat affects expression EXP 6480464 pevonedistat affects the expression of BCL2L11 mRNA and pevonedistat affects the expression of BCL2L11 protein CTD PMID:24634471 BCL2L11 Human PF-4708671 multiple interactions EXP 6480464 [NVP-BSK805 co-treated with PF-4708671] results in increased expression of BCL2L11 protein modified form CTD PMID:26242912 BCL2L11 Human phenobarbital decreases expression ISO Bcl2l11 (Mus musculus) 6480464 Phenobarbital results in decreased expression of BCL2L11 mRNA CTD PMID:19270015 BCL2L11 Human phenobarbital affects expression ISO Bcl2l11 (Mus musculus) 6480464 Phenobarbital affects the expression of BCL2L11 mRNA CTD PMID:23091169 BCL2L11 Human phenobarbital increases expression ISO Bcl2l11 (Mus musculus) 6480464 Phenobarbital results in increased expression of BCL2L11 mRNA CTD PMID:25270620 BCL2L11 Human phenylmercury acetate decreases expression EXP 6480464 Phenylmercuric Acetate results in decreased expression of BCL2L11 mRNA CTD PMID:26272509 BCL2L11 Human phenylmercury acetate multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BCL2L11 mRNA CTD PMID:27188386 BCL2L11 Human phloretin multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 Phloretin inhibits the reaction [[cobaltous chloride co-treated with lipopolysaccharide and E coli O55-B5] results in increased expression of BCL2L11 protein] CTD PMID:32408695 BCL2L11 Human picoxystrobin decreases expression EXP 6480464 picoxystrobin results in decreased expression of BCL2L11 mRNA CTD PMID:33512557 BCL2L11 Human pinostrobin increases expression EXP 6480464 pinostrobin results in increased expression of BCL2L11 mRNA CTD PMID:37777166 BCL2L11 Human pirinixic acid increases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 pirinixic acid results in increased expression of BCL2L11 mRNA CTD PMID:12832660 BCL2L11 Human ponatinib multiple interactions EXP 6480464 (+)-JQ1 compound promotes the reaction [ponatinib results in increased expression of BCL2L11 protein] and ponatinib promotes the reaction [(+)-JQ1 compound results in increased expression of BCL2L11 protein] CTD PMID:25053825 BCL2L11 Human ponatinib increases expression EXP 6480464 ponatinib results in increased expression of BCL2L11 protein CTD PMID:25053825 BCL2L11 Human potassium chromate increases expression EXP 6480464 potassium chromate(VI) results in increased expression of BCL2L11 mRNA CTD PMID:17382205 BCL2L11 Human Pramanicin increases expression EXP 6480464 pramanicin analog results in increased expression of BCL2L11 protein CTD PMID:23441183 BCL2L11 Human Pramanicin affects response to substance EXP 6480464 BCL2L11 protein affects the susceptibility to pramanicin CTD PMID:23441183 BCL2L11 Human proanthocyanidin decreases expression ISO Bcl2l11 (Mus musculus) 6480464 Proanthocyanidins results in decreased expression of BCL2L11 mRNA CTD PMID:29205955 BCL2L11 Human prochloraz increases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 prochloraz results in increased expression of BCL2L11 mRNA CTD PMID:29038839 BCL2L11 Human procyanidin B2 multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 procyanidin B2 inhibits the reaction [Diquat results in increased expression of BCL2L11 mRNA] and procyanidin B2 inhibits the reaction [Hydrogen Peroxide results in increased expression of BCL2L11 mRNA] CTD PMID:27057282 BCL2L11 Human propylparaben increases expression EXP 6480464 propylparaben results in increased expression of BCL2L11 mRNA CTD PMID:24481588 BCL2L11 Human protein kinase inhibitor multiple interactions EXP 6480464 Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of BCL2L11 mRNA] CTD PMID:28003376 BCL2L11 Human pyrethrins increases expression EXP 6480464 Pyrethrins results in increased expression of BCL2L11 mRNA CTD PMID:35321623 BCL2L11 Human quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of BCL2L11 protein CTD PMID:20438634 BCL2L11 Human quercetin increases expression EXP 6480464 Quercetin results in increased expression of BCL2L11 mRNA and Quercetin results in increased expression of BCL2L11 protein CTD PMID:25339540 and PMID:30152185 BCL2L11 Human quizartinib increases expression EXP 6480464 quizartinib results in increased expression of BCL2L11 protein CTD PMID:25053825 BCL2L11 Human quizartinib multiple interactions EXP 6480464 (+)-JQ1 compound promotes the reaction [quizartinib results in increased expression of BCL2L11 protein] and quizartinib promotes the reaction [(+)-JQ1 compound results in increased expression of BCL2L11 protein] CTD PMID:25053825 BCL2L11 Human raloxifene increases expression EXP 6480464 Raloxifene Hydrochloride results in increased expression of BCL2L11 mRNA CTD PMID:19429434 BCL2L11 Human reactive oxygen species multiple interactions EXP 6480464 [[[CD40LG protein co-treated with IL4 protein] results in increased abundance of Reactive Oxygen Species] which results in increased expression of and results in increased phosphorylation of and results in increased stability of TP53 protein] which results in decreased expression of BCL2L11 protein CTD PMID:27634759 BCL2L11 Human Rebamipide multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rebamipide results in decreased expression of BCL2L11 protein] more ... CTD PMID:29054700 BCL2L11 Human Rebamipide decreases expression EXP 6480464 rebamipide results in decreased expression of BCL2L11 protein CTD PMID:29054700 BCL2L11 Human remdesivir increases expression EXP 6480464 remdesivir results in increased expression of BCL2L11 protein CTD PMID:35417658 BCL2L11 Human resveratrol multiple interactions EXP 6480464 BCL2L11 protein promotes the reaction [resveratrol results in increased activity of BAK1 protein] more ... CTD PMID:21179458 more ... BCL2L11 Human resveratrol multiple interactions ISO Bcl2l11 (Rattus norvegicus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein]] and resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein] CTD PMID:25471227 BCL2L11 Human resveratrol increases expression ISO Bcl2l11 (Mus musculus) 6480464 resveratrol results in increased expression of BCL2L11 protein CTD PMID:20026400 and PMID:21980390 BCL2L11 Human resveratrol increases expression EXP 6480464 resveratrol results in increased expression of BCL2L11 protein and resveratrol results in increased expression of BCL2L11 protein alternative form CTD PMID:17636462 more ... BCL2L11 Human resveratrol increases response to substance EXP 6480464 BCL2L11 protein results in increased susceptibility to resveratrol CTD PMID:22245142 BCL2L11 Human romidepsin multiple interactions EXP 6480464 [Bortezomib co-treated with romidepsin] results in increased expression of BCL2L11 protein more ... CTD PMID:15173094 and PMID:27634878 BCL2L11 Human romidepsin increases expression EXP 6480464 romidepsin results in increased expression of BCL2L11 protein CTD PMID:15069698 more ... BCL2L11 Human rotenone increases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 Rotenone results in increased expression of BCL2L11 mRNA CTD PMID:28374803 BCL2L11 Human rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of BCL2L11 mRNA CTD PMID:33512557 and PMID:36586010 BCL2L11 Human ryanodine multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 [Ryanodine co-treated with Halothane] results in increased expression of BCL2L11 mRNA CTD PMID:32795494 BCL2L11 Human S-allylcysteine multiple interactions ISO Bcl2l11 (Rattus norvegicus) 6480464 S-allylcysteine inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of BCL2L11 protein] CTD PMID:16030430 BCL2L11 Human sapanisertib increases expression EXP 6480464 sapanisertib results in increased expression of BCL2L11 mRNA and sapanisertib results in increased expression of BCL2L11 protein CTD PMID:26536665 BCL2L11 Human sarin increases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 Sarin results in increased expression of BCL2L11 mRNA CTD PMID:16733813 BCL2L11 Human SB 203580 multiple interactions ISO Bcl2l11 (Rattus norvegicus) 6480464 SB 203580 inhibits the reaction [sodium arsenite results in increased phosphorylation of BCL2L11 protein] CTD PMID:16818494 BCL2L11 Human SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 BCL2L11 Human Se-methyl-L-selenocysteine increases expression EXP 6480464 selenomethylselenocysteine metabolite results in increased expression of BCL2L11 mRNA CTD PMID:25321483 BCL2L11 Human Se-methylselenocysteine increases expression EXP 6480464 selenomethylselenocysteine metabolite results in increased expression of BCL2L11 mRNA CTD PMID:25321483 BCL2L11 Human selenium atom multiple interactions EXP 6480464 BCL2L11 protein affects the susceptibility to [Doxorubicin co-treated with Selenium] more ... CTD PMID:17339365 BCL2L11 Human selenium atom increases expression EXP 6480464 Selenium results in increased expression of BCL2L11 protein CTD PMID:17339365 BCL2L11 Human selumetinib increases expression EXP 6480464 AZD 6244 results in increased expression of BCL2L11 protein CTD PMID:22729845 BCL2L11 Human serpentine asbestos decreases expression ISO Bcl2l11 (Mus musculus) 6480464 Asbestos and Serpentine results in decreased expression of BCL2L11 protein CTD PMID:19116364 BCL2L11 Human serpentine asbestos multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 PRKD1 protein affects the reaction [Asbestos more ... CTD PMID:19116364 BCL2L11 Human silicon dioxide decreases expression EXP 6480464 Silicon Dioxide analog results in decreased expression of BCL2L11 mRNA and Silicon Dioxide results in decreased expression of BCL2L11 mRNA CTD PMID:25351596 and PMID:25895662 BCL2L11 Human silicon dioxide decreases methylation EXP 6480464 Silicon Dioxide results in decreased methylation of BCL2L11 gene CTD PMID:34973136 BCL2L11 Human silicon dioxide increases expression ISO Bcl2l11 (Mus musculus) 6480464 Silicon Dioxide results in increased expression of BCL2L11 mRNA CTD PMID:19073995 BCL2L11 Human sirolimus multiple interactions EXP 6480464 [Cisplatin inhibits the reaction [[Sirolimus results in increased phosphorylation of AKT1 protein] which results in increased phosphorylation of FOXO3 protein]] which results in increased expression of BCL2L11 protein more ... CTD PMID:21092744 and PMID:29054700 BCL2L11 Human sirolimus decreases expression ISO Bcl2l11 (Mus musculus) 6480464 Sirolimus results in decreased expression of BCL2L11 protein CTD PMID:18097008 BCL2L11 Human sirolimus increases expression EXP 6480464 Sirolimus results in increased expression of BCL2L11 protein CTD PMID:21092744 BCL2L11 Human sodium arsenite increases expression ISO Bcl2l11 (Mus musculus) 6480464 sodium arsenite results in increased expression of BCL2L11 mRNA CTD PMID:16166651 BCL2L11 Human sodium arsenite increases response to substance ISO Bcl2l11 (Rattus norvegicus) 6480464 BCL2L11 protein results in increased susceptibility to sodium arsenite CTD PMID:16818494 BCL2L11 Human sodium arsenite increases phosphorylation ISO Bcl2l11 (Rattus norvegicus) 6480464 sodium arsenite results in increased phosphorylation of BCL2L11 protein CTD PMID:16818494 BCL2L11 Human sodium arsenite increases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 sodium arsenite results in increased expression of BCL2L11 protein alternative form CTD PMID:20830294 BCL2L11 Human sodium arsenite decreases expression ISO Bcl2l11 (Mus musculus) 6480464 sodium arsenite results in decreased expression of BCL2L11 mRNA CTD PMID:19822182 BCL2L11 Human sodium arsenite multiple interactions ISO Bcl2l11 (Rattus norvegicus) 6480464 SB 203580 inhibits the reaction [sodium arsenite results in increased phosphorylation of BCL2L11 protein] more ... CTD PMID:16818494 and PMID:20830294 BCL2L11 Human sodium arsenite multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 CEP-11004 inhibits the reaction [sodium arsenite results in increased expression of BCL2L11 protein] more ... CTD PMID:16166651 BCL2L11 Human sodium chloride multiple interactions ISO Bcl2l11 (Rattus norvegicus) 6480464 [Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of BCL2L11 protein and S-allylcysteine inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of BCL2L11 protein] CTD PMID:16030430 BCL2L11 Human sodium chromate multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 [sodium chromate(VI) results in increased abundance of chromium hexavalent ion] which results in increased expression of BCL2L11 mRNA and Melatonin inhibits the reaction [[sodium chromate(VI) results in increased abundance of chromium hexavalent ion] which results in increased expression of BCL2L11 mRNA] CTD PMID:35643323 BCL2L11 Human sorafenib affects localization EXP 6480464 sorafenib affects the localization of BCL2L11 protein CTD PMID:18200035 BCL2L11 Human sorafenib increases expression EXP 6480464 sorafenib results in increased expression of BCL2L11 protein CTD PMID:18200035 BCL2L11 Human sorafenib decreases expression EXP 6480464 sorafenib results in decreased expression of BCL2L11 protein CTD PMID:16109713 BCL2L11 Human sorafenib multiple interactions EXP 6480464 [sorafenib co-treated with 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3 and 2-d)pyrimidine] results in increased expression of BCL2L11 protein CTD PMID:23036488 BCL2L11 Human streptozocin increases expression ISO Bcl2l11 (Mus musculus) 6480464 Streptozocin results in increased expression of BCL2L11 mRNA CTD PMID:33524429 BCL2L11 Human streptozocin multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 Chlorpyrifos promotes the reaction [Streptozocin results in increased expression of BCL2L11 mRNA] CTD PMID:33524429 BCL2L11 Human succimer multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of BCL2L11 mRNA and [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of BCL2L11 mRNA CTD PMID:21641980 and PMID:26378955 BCL2L11 Human succimer multiple interactions EXP 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BCL2L11 mRNA CTD PMID:26378955 BCL2L11 Human sunitinib increases expression EXP 6480464 Sunitinib results in increased expression of BCL2L11 mRNA CTD PMID:31533062 BCL2L11 Human tamoxifen multiple interactions EXP 6480464 Tamoxifen promotes the reaction [methylselenic acid results in increased cleavage of BCL2L11 protein] CTD PMID:18790785 BCL2L11 Human tanespimycin increases expression EXP 6480464 tanespimycin results in increased expression of BCL2L11 protein CTD PMID:24784839 BCL2L11 Human taurine multiple interactions ISO Bcl2l11 (Rattus norvegicus) 6480464 Taurine inhibits the reaction [sodium arsenite results in increased expression of BCL2L11 protein alternative form] CTD PMID:20830294 BCL2L11 Human temozolomide increases expression EXP 6480464 temozolomide results in increased expression of BCL2L11 mRNA and temozolomide results in increased expression of BCL2L11 protein CTD PMID:26418950 BCL2L11 Human temozolomide multiple interactions EXP 6480464 BCL2L11 mutant form inhibits the reaction [temozolomide results in increased cleavage of CASP9 protein] and pyrazolanthrone inhibits the reaction [temozolomide results in increased expression of BCL2L11 mRNA] CTD PMID:26418950 BCL2L11 Human testosterone increases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 Testosterone deficiency results in increased expression of BCL2L11 protein CTD PMID:20850791 BCL2L11 Human testosterone decreases expression EXP 6480464 Testosterone results in decreased expression of BCL2L11 mRNA CTD PMID:33359661 BCL2L11 Human tetrachloromethane increases expression ISO Bcl2l11 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of BCL2L11 mRNA and Carbon Tetrachloride results in increased expression of BCL2L11 protein CTD PMID:17482686 BCL2L11 Human tetrachloromethane decreases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in decreased expression of BCL2L11 mRNA CTD PMID:33387578 BCL2L11 Human tetrachloromethane multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 PLG protein affects the reaction [Carbon Tetrachloride results in increased expression of BCL2L11 protein] CTD PMID:17482686 BCL2L11 Human tetrathiomolybdate(2-) multiple interactions ISO Bcl2l11 (Rattus norvegicus) 6480464 [Copper deficiency co-treated with tetrathiomolybdate] results in increased cleavage of BCL2L11 protein and [Copper deficiency co-treated with tetrathiomolybdate] results in increased expression of BCL2L11 protein CTD PMID:22276220 BCL2L11 Human thioacetamide increases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of BCL2L11 mRNA CTD PMID:23411599 and PMID:34492290 BCL2L11 Human thiram increases expression EXP 6480464 Thiram results in increased expression of BCL2L11 mRNA CTD PMID:38568856 BCL2L11 Human titanium dioxide decreases methylation ISO Bcl2l11 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of BCL2L11 gene and titanium dioxide results in decreased methylation of BCL2L11 promoter CTD PMID:35295148 BCL2L11 Human Tomentosin increases expression EXP 6480464 tomentosin results in increased expression of BCL2L11 protein CTD PMID:32787465 BCL2L11 Human trametinib multiple interactions EXP 6480464 [trametinib co-treated with omipalisib] results in increased expression of BCL2L11 protein CTD PMID:22733540 BCL2L11 Human trametinib increases expression EXP 6480464 trametinib results in increased expression of BCL2L11 protein CTD PMID:22733540 BCL2L11 Human Tributyltin oxide increases expression ISO Bcl2l11 (Mus musculus) 6480464 bis(tri-n-butyltin)oxide results in increased expression of BCL2L11 mRNA CTD PMID:22434021 BCL2L11 Human trichostatin A multiple interactions EXP 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:14575637 and PMID:27188386 BCL2L11 Human trichostatin A decreases expression EXP 6480464 trichostatin A results in decreased expression of BCL2L11 mRNA CTD PMID:24935251 and PMID:26272509 BCL2L11 Human trichostatin A increases expression EXP 6480464 trichostatin A results in increased expression of BCL2L11 mRNA CTD PMID:24935251 BCL2L11 Human trimellitic anhydride increases expression ISO Bcl2l11 (Mus musculus) 6480464 trimellitic anhydride results in increased expression of BCL2L11 mRNA CTD PMID:19042947 BCL2L11 Human triphenyl phosphate increases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 triphenyl phosphate results in increased expression of BCL2L11 mRNA CTD PMID:30589522 BCL2L11 Human triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of BCL2L11 mRNA CTD PMID:37042841 BCL2L11 Human triptonide increases expression ISO Bcl2l11 (Mus musculus) 6480464 triptonide results in increased expression of BCL2L11 mRNA CTD PMID:33045310 BCL2L11 Human troglitazone decreases expression ISO Bcl2l11 (Mus musculus) 6480464 troglitazone results in decreased expression of BCL2L11 mRNA CTD PMID:28973697 BCL2L11 Human tunicamycin multiple interactions EXP 6480464 Arsenic Trioxide inhibits the reaction [Tunicamycin results in increased expression of BCL2L11 protein] CTD PMID:36509116 BCL2L11 Human tunicamycin increases expression EXP 6480464 Tunicamycin results in increased expression of BCL2L11 protein CTD PMID:36509116 BCL2L11 Human urethane increases expression EXP 6480464 Urethane results in increased expression of BCL2L11 mRNA CTD PMID:28818685 BCL2L11 Human usnic acid decreases expression EXP 6480464 usnic acid results in decreased expression of BCL2L11 mRNA CTD PMID:32508146 BCL2L11 Human valproic acid affects expression ISO Bcl2l11 (Mus musculus) 6480464 Valproic Acid affects the expression of BCL2L11 mRNA CTD PMID:17963808 BCL2L11 Human valproic acid multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 and PMID:32623605 BCL2L11 Human valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of BCL2L11 mRNA CTD PMID:23179753 more ... BCL2L11 Human valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of BCL2L11 mRNA CTD PMID:32623605 BCL2L11 Human valsartan multiple interactions ISO Bcl2l11 (Rattus norvegicus) 6480464 Valsartan inhibits the reaction [Cyclophosphamide results in increased expression of BCL2L11 mRNA] CTD PMID:32197949 BCL2L11 Human vemurafenib multiple interactions EXP 6480464 [BRAF protein mutant form results in increased susceptibility to vemurafenib] which results in increased expression of BCL2L11 protein and [MET protein affects the susceptibility to HGF protein] affects the reaction [[BRAF protein mutant form results in increased susceptibility to vemurafenib] which results in increased expression of BCL2L11 protein] CTD PMID:27689874 BCL2L11 Human vorinostat multiple interactions EXP 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:19509267 and PMID:27188386 BCL2L11 Human vorinostat increases expression ISO Bcl2l11 (Rattus norvegicus) 6480464 vorinostat results in increased expression of BCL2L11 mRNA and vorinostat results in increased expression of BCL2L11 protein CTD PMID:17331788 BCL2L11 Human vorinostat increases expression EXP 6480464 vorinostat results in increased expression of BCL2L11 mRNA more ... CTD PMID:16144943 more ... BCL2L11 Human withaferin A decreases expression EXP 6480464 withaferin A results in decreased expression of BCL2L11 protein CTD PMID:20438634 BCL2L11 Human withaferin A multiple interactions ISO Bcl2l11 (Rattus norvegicus) 6480464 withaferin A inhibits the reaction [Cholesterol and Dietary results in increased expression of BCL2L11 protein] CTD PMID:35734936 BCL2L11 Human xanthohumol increases expression EXP 6480464 xanthohumol results in increased expression of BCL2L11 alternative form CTD PMID:35229981 BCL2L11 Human zinc atom increases expression EXP 6480464 Zinc results in increased expression of BCL2L11 mRNA CTD PMID:19071009 BCL2L11 Human zinc protoporphyrin increases expression EXP 6480464 zinc protoporphyrin results in increased expression of BCL2L11 protein CTD PMID:27829220 BCL2L11 Human zinc(0) increases expression EXP 6480464 Zinc results in increased expression of BCL2L11 mRNA CTD PMID:19071009 BCL2L11 Human zoledronic acid multiple interactions EXP 6480464 [zoledronic acid co-treated with fluvastatin] results in increased expression of BCL2L11 mRNA CTD PMID:16996129
